Diagnosis of giant cell arteritis. (29th April 2020)

• Record Type: Journal Article
• Authors: Ponte, Cristina; Martins-Martinho, Joana; Luqmani, Raashid Ahmed
• Is Part Of: Rheumatology. Volume 59(2020)Supplement 3
• Page Start: iii5
• Page End: iii16
• Publication Date: 2020-04-29
• Subjects: giant cell arteritis -- diagnosis -- temporal artery biopsy -- ultrasound -- magnetic resonance -- computed tomography -- positron emission tomography -- imaging; Rheumatism -- Periodicals; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1093/rheumatology/kez553
• Languages: English
• ISSNs: 1462-0324

Abstract

Abstract: GCA is the most common form of primary systemic vasculitis affecting older people. It is considered a clinical emergency because it can lead to irreversible blindness in around 20% of untreated cases. High doses of glucocorticoids should be initiated promptly to prevent disease-related complications; however, glucocorticoids therapy usually results in significant toxicity. Therefore, correct diagnosis is crucial. For many years, temporal artery biopsy has been considered the diagnostic 'gold standard' for GCA, but it has many limitations (including low sensitivity). US has proven to be effective for diagnosing GCA and can reliably replace temporal artery biopsy in particular clinical settings. In cases of suspected GCA with large-vessel involvement, other imaging modalities can be used for diagnosis (e.g. CT and PET). Here we review the current evidence for each diagnostic modality and propose an algorithm to diagnose cranial-GCA in a setting with rapid access to high quality US.